GoodRx Holdings, Inc.’s partnership with Novo Nordisk highlights its vital role in direct-to-consumer drug pricing. Click here to find out why GDRX is a Buy.
GoodRx: After A 30% Surge On The Novo News, Is The Story Just Beginning?
view original post